Moreover, while we observed association of high ET-1 with increased risk of mortality, the current data does not allow to determine if high ET-1 was also a cause for higher risk of death, which would suggest potential for ET-1 receptor antagonists to reduce mortality in CAD patients with high ET-1. The gene discussed is EDN1; the disease is coronary artery disorder.